GSK Investigational Site
Macquarie University, New South Wales 2109
1 studies enrolling now · 3 studies all time
What they study most
Asthma, Cough, Neoplasms, Refractory Chronic Cough, Solid Tumors
Studies at this site
- A Study to Evaluate the Safety,Tolerability, Pharmacokinetics and Clinical Activity of Mocertatug Rezetecan for Injection in Participants With Advanced Solid Tumors (BEHOLD-1) — Recruiting now
- A 24-Week Study of the Efficacy and Safety of BLU-5937 in Adults With Refractory Chronic Cough — Running, not enrolling
- A Study of GSK3511294 (Depemokimab) Compared With Mepolizumab or Benralizumab in Participants With Severe Asthma With an Eosinophilic Phenotype — Completed